Admission to the Official List and to trading on the Main Market of the London Stock Exchange

InnovaDerma PLC (the “Company”), a UK developer of ‘at-home’ and clinically-proven treatments for hair loss, hair care, selftanning
and skin rejuvenation today announces that its entire issued share capital consisting of 10,318,535 ordinary shares of
€0.10 each (the “Ordinary Shares”) will today be admitted to the standard segment of the Official List of the UK Listing

Authority and to trading on the Main Market for listed securities of the London Stock Exchange (together “Admission”).
Dealings are expected to commence at 8:00 a.m. under the TIDM code “IDP” (ISIN: GBOOBT9PTW34). The Ordinary Shares
already trade under the TIDM code “MLIDP” on the Marché Libre operated by Euronext Paris SA. It is the Company’s
intention to delist its Ordinary Shares from the Marché Libre.

The Prospectus and Supplementary Prospectus published by the Company on 25 July 2016 and on 2 September 2016,
respectively, in connection with this Admission can be found on the Company’s website at

Mr. HarisChaudhry, Executive Chairman and Founder of InnovaDerma said:
“With our strong brands, which have an international presence, and the excellent progress made by the Group, the
opportunities that lie ahead make this an exciting time for us to bring InnovaDerma to the London Stock Exchange.”

Further enquiries
Haris Chaudhry/Joe Bayer +61 (0)3 9111 0071
Sole broker
Hybridan LLP
Claire Noyce/Niall Pearson
+44 (0)203 764 2341 / 2343
Cardew Group
Shan Shan Willenbrock
David Roach
Emma Ruttle
+44 (0)20 7930 0777

About InnovaDerma:

InnovaDerma PLC specialises in the research, manufacture and marketing of clinically proven products in hair loss, antiageing
and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South
Africa, Hong Kong and South Korea.